Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
21 Bridge Street
Metuchen, NJ 08840, USA
Tel/Fax:
+1 801-751-5728
info@pharmachinaonline.com
Affiliated Companies
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
BJ Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel:
+86 10 84476010
info@pharmachinaonline.com
News
2/26/2021
CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...
2/26/2021
Spring Promotion - Pharma China Publications
(Free)
2/26/2021
NMPA Announces Package Insert Revision of Misoprostol Tablets
2/26/2021
Recent Executive Moves
2/26/2021
Financial-related Company News in Brief
2/26/2021
241 A Share-Listed Chinese MedPharm Cos Release 2020 Performance Guida...
2/25/2021
Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...
2/25/2021
Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...
2/25/2021
China Approves Two More Domestic COVID-19 Vaccines
(Free)
2/25/2021
Snapshot of BMI System Financial Performance in 2020
2/25/2021
AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...
More>>
Feature Articles
2/25/2021
CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...
2/25/2021
Biosecurity Law of the P.R.C. - Full Text Unofficial Translation
2/25/2021
PharmaNJ's China NMPA Approved Tracker: Jan 2021
2/23/2021
PharmaDJ's China Licensing Deals Tracker: Jan 2021
2/23/2021
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
2/22/2021
The Race to the Top: Does China Have What It Takes?
2/22/2021
How Foreign Companies Can Break Into China's Biosimilar Market and Rel...
2/9/2021
NLR: China's Patent Office Releases Draft Measures for Patent Linkage ...
2/9/2021
SCMP: Phase One Trade Deal Largely A "Failure", As Purchases Fall Well...
2/8/2021
Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
2/4/2021
Changes To Biotech And Chemical Patent Examination - Recent Amendments...
More>>
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit